Presented at the NORD Breakthrough Summit, the findings show EDS patients wait a median of nearly eight years for a...
KFSH Mobile Stroke Unit KFSH emergency staff beside a mobile stroke unit in Riyadh RIYADH, Saudi Arabia, Oct. 24, 2026...
LONDON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd., a subsidiary of Claritas HealthTech Ltd, today announced that...
Submission marks an important milestone towards bringing a new treatment option to patients with DMD in South Korea. Vamorolone has already...
Privosegtor reduced post-onset increases in plasma neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) compared with placebo Lower...
Privosegtor reduced post-onset increases in plasma neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) compared with placebo Lower...
Ad hoc announcement pursuant to Art. 53 LRBasel, 22 October 2026 Roche continues strong momentum in the third quarter with...
Continued strong VYVGART performance drives $1.7 billion in global product net sales, representing 54% year-over-year growth and 13% quarter-over-quarter growth...
Key HighlightsRecord revenue: preliminary nine-month 2026 revenue of approximately $54.3 million, up 19%, with every quarter of 2026 setting a...
Director of the Montefiore Headache Center and past President of the American Headache Society joins Professor Peter Goadsby in leading...
FDA approval based on Phase III SatraGO-1 and -2 studies, with SatraGO-2 demonstrating a significant reduction in eye bulging (proptosis)...
Will lead Evotec's global scientific strategy and drive differentiation across its discovery and development services, technology platforms and proprietary innovationBrings...
HOUSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive...
Dr. Robin Carhart-Harris has signed a new agreement to serve as Scientific Advisor to Rhelion Life Sciences and its wholly...
Brain Prize co-recipient whose research identified CGRP as a central driver of migraine joins to guide development of BETR-001 in...
In the MEERKAT and SANDCAT studies, vamikibart demonstrated sustained improvements in vision and reductions in macular thickness in patients with...
PRESS RELEASE AB SCIENCE REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026 AND KEY EVENTS OF THE PERIOD...
Research presented at ISFTD 2026 connects measurements from the living brain with disease patterns confirmed through postmortem analysis Mapping cortical...
Full-text content and visuals from the JAMA Network will inform answers delivered through ClinicalKey AINEW YORK, Oct. 7, 2026 /PRNewswire/...
GigHz highlights a peer-reviewed analysis of 1,430 authorization records and the broader question of what it will take to bring...